O'Brien J - Search Results

1

Immune function and vaccine responses in healthy advanced elderly patients.

Carson PJ, Nichol KL, O'Brien J, Hilo P, Janoff EN. Carson PJ, et al. Arch Intern Med. 2000 Jul 10;160(13):2017-24. doi: 10.1001/archinte.160.13.2017. Arch Intern Med. 2000. PMID: 10888975

2

Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients.

Carson PJ, Schut RL, Simpson ML, O'Brien J, Janoff EN. Carson PJ, et al. J Infect Dis. 1995 Aug;172(2):340-5. doi: 10.1093/infdis/172.2.340. J Infect Dis. 1995. PMID: 7622875

3

Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.

Weiss PJ, Wallace MR, Oldfield EC 3rd, O'Brien J, Janoff EN. Weiss PJ, et al. J Infect Dis. 1995 May;171(5):1217-22. doi: 10.1093/infdis/171.5.1217. J Infect Dis. 1995. PMID: 7751696

4

Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection.

Janoff EN, O'Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, Douglas JM Jr. Janoff EN, et al. J Infect Dis. 1993 Jan;167(1):49-56. doi: 10.1093/infdis/167.1.49. J Infect Dis. 1993. PMID: 8093364

5

Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine.

Janoff EN, Fasching C, Ojoo JC, O'Brien J, Gilks CF. Janoff EN, et al. J Infect Dis. 1997 Apr;175(4):975-8. doi: 10.1086/514004. J Infect Dis. 1997. PMID: 9086163

6

Immune activation and virologic response to immunization in recent HIV type 1 seroconverters.

Janoff EN, Tasker SA, Stevenson M, Rubins JB, O'Brien J, Utz G, Weiss P, Hall FW, Wallace MR. Janoff EN, et al. AIDS Res Hum Retroviruses. 1999 Jun 10;15(9):837-45. doi: 10.1089/088922299310746. AIDS Res Hum Retroviruses. 1999. PMID: 10381172

7

Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine.

Arpadi SM, Back S, O'Brien J, Janoff EN. Arpadi SM, et al. J Pediatr. 1994 Jul;125(1):77-9. doi: 10.1016/s0022-3476(94)70127-x. J Pediatr. 1994. PMID: 8021792

8

Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses.

Tasker SA, Wallace MR, Rubins JB, Paxton WB, O'Brien J, Janoff EN. Tasker SA, et al. Clin Infect Dis. 2002 Mar 15;34(6):813-21. doi: 10.1086/339044. Epub 2002 Feb 7. Clin Infect Dis. 2002. PMID: 11850863 Clinical Trial.

9

Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures.

French N, Gilks CF, Mujugira A, Fasching C, O'Brien J, Janoff EN. French N, et al. AIDS. 1998 Sep 10;12(13):1683-9. doi: 10.1097/00002030-199813000-00017. AIDS. 1998. PMID: 9764789 Clinical Trial.

10

Evaluating dextrorphan as a wastewater biomarker for cough suppressant use: A longitudinal study in China.

Shao XT, Ma XD, Li JL, O'Brien JW, Thomas K, Wang DG. Shao XT, et al. Among authors: o brien jw. Water Res. 2025 Jun 27;285:124119. doi: 10.1016/j.watres.2025.124119. Online ahead of print. Water Res. 2025. PMID: 40602061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,030 results

Search Page

Filters